Big Market Research, iBio Inc product pipeline market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘iBio, Inc. - Product Pipeline Review - 2014’, provides an overview of the iBio, Inc.’s pharmaceutical research and development focus.
Big Market Research, Medicago S.P.A Product Pipeline Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Medicago Inc. - Product Pipeline Review - 2014’, provides an overview of the Medicago Inc.’s pharmaceutical research and development focus.
Big Market Research, Nuvilex Inc Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘Nuvilex, Inc. - Product Pipeline Review - 2014’, provides an overview of the Nuvilex, Inc.’s pharmaceutical research and development focus.
Big Market Research, Anchor Therapeutics Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Anchor Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Anchor Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Anchor Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, Retrophin Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘Retrophin Inc. - Product Pipeline Review - 2014’, provides an overview of the Retrophin Inc.’s pharmaceutical research and development focus.
AnGes MG, Inc. - Product Pipeline Review - 2014 Big Market Research, AnGes MG Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘AnGes MG, Inc. - Product Pipeline Review - 2014’, provides an overview of the AnGes MG Inc.’s pharmaceutical research and development focus.
Big Market Research, EpiVax Inc. Product Pipeline Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘EpiVax, Inc. - Product Pipeline Review - 2014’, provides an overview of the EpiVax, Inc.’s pharmaceutical research and development focus
Big Market Research, Axikin Pharmaceuticals Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Axikin Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Axikin Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Axikin Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Immunetics Inc. (Immunetics) offers assay technology for blood screening and infectious disease diagnosis. It is one of the leading innovator of tests for bacterial, viral, and parasitic diseases. It produces and markets a wide range of infectious disease assay kits and instruments. Immunetics has issued patents on its BacTx test for bacterial contamination of platelets.
Sialix, Inc. (Sialix) develops products for treatment and prevention of the cancer and chronic inflammatory conditions. It products are based on the new biological discoveries of non-human sialic acids; dietary roles and inflammatory consequences; their potential impact on cardiovascular, cancer; and other inflammatory-mediated diseases.
BioSET, Inc (BioSET) is a medical equipment as well as drug manufacturer company. The company has expertise in developing orthobiologic devices. Its products are next-generation combination devices that couples with bioactive peptides with tissue-specific scaffolds. Its main product is AMPLEX device which is a combination of the B2A peptide and a synthetic ceramic scaffold with chemical properties similar to that of native bone.
EndoStim, Inc (EndoStim) is a medical device company. The company focuses on the treatment of Gastro-esophageal Reflux Disease (GERD) through electrical stimulation. EndoStimhas uses low energy electrical pulses to strengthen a weak or dysfunctional lower esophageal sphincter (LES) muscle which is the underlying cause of GERD or acid reflux.
OrthoSensor, Inc. (OrthoSensor) is a medical device company. OrthoSensor develops and commercializes intelligent orthopedic devices which offers real time data to surgeons and hospitals during and after surgery.
Aaren Scientific Inc.(Aaren Scientific), formerly Ophthalmic Innovations International, is a medical device company. The company designs, develops, manufactures and markets intraocular lenses and surgical products for the ophthalmic industry.
Rheonix, Inc. (Rheonix) is a diagnostic systems developer. It develops patented Rheonix CARD system and EncompassMDx instrument. Rheonix CARD system manipulates reagents with an internal active fluidized network of pumps, valves and channels. The company performs molecular techniques such as sample preparation, amplification and detection.
Alliqua Biomedical, Inc. (Alliqua Biomedical) focuses on development of proprietary products for wound care dressings and a core transdermal delivery technology platform. The company has exclusive worldwide license to use Noble Fiber Technologies, LLCs silver coated fibers marketed under the trademarks X-Static and SilverSeal. The company is headquatered in NewYork, the US.
Big Market Research, Tetraphase Pharmaceuticals Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014.Global Markets Direct’s, ‘Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Tetraphase Pharmaceuticals Inc.’s pharmaceutical research and development focus.
Cancer Genetics, Inc. (CGI) is the leader in the field of personalized medicine. It offers cancer diagnostics and treatments tailoring the specific genetic profile of the individual. The diagnostic assays and products offered by the company are designed to increase treatment efficacy and reduce healthcare costs of the hematological, urogenital and HPV-associated cancers
Ocular Therapeutix, Inc. (Ocular ) develops ophthalmic therapeutic products using hydrogel technology. The hydrogel technology consists of polyethylene glycol (PEG), widely considered an inert and biocompatible material which can be customized as per the use.
Kai Medical, Inc. (Kai Medical) formerly, Kai Sensors, Inc., develps medical devices to measure and monitor respiratory ailments. The product portfolio of the company comprises Kai Spot used to measure a patient’s point-in-time respiratory rate, Kai Apnea used to treat adults with obstructive sleep apnea and the Kai Continuous used to continuously measure a patient’s respiratory waveform and rate. Kai Medical is headquartered in Honolulu, Hawaii, the US.
MicroTransponder Inc. (MicroTransponder) is a medical device company. It is a spun out from the University of Texas. The company carries out the development of neurostimulation solutions to treat neurological diseases.
IV Diagnostics, Inc. (IV Diagnostics) is a biomedical diagnostic company that concentrates on molecular diagnostic tests for circulating tumor cells and other blood borne diseases. The company develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. Its IVDxTx platform technology, allows physicians to perform real-time diagnosis of the patient’s circulating tumor cells (CTCs) without collecting blood.
Gamma Therapeutics, Inc. (Gamma Therapeutics), an early stage biotechnology company. It focuses on developing solutions for cardiovascular disease risk assessment, surgical therapy and combat casualty care.
NeuroInterventional Therapeutics, Inc. (NeuroInterventional) designs and manufactures catheter systems. The catheter systems are used to find, trap and extract thrombus in cerebral vessels, thus increasing chances of survival and minimizing disability. The company intends to use catheters for variety of clinical conditions includng stroke, deep vein thrombosis, acute myocardial ischemia, and peripheral arterial disease.
EyeKon Medical, Inc.(EyeKon) is a medical device manufacturer of capsular tension rings (CTR), intraocular lenses ( IOL ) and viscoelastic. It designs, develops and manufacture ophthalmic surgical devices by using the finest materials, quality control practices and workmanship.
MBio Diagnostics, Inc (MBio) is a medical equipment company. It delivers testing systems for the rapid diagnosis and management of multiple diseases simultaneously with the help of its innovative optical technology
Nuclea Biotechnologies Inc. (Nuclea) is a translational medicine company. It carries out the discovery of proprietary biomarkers and in vitro companion diagnostic assays. The company’s vitro companion diagnostics are used in therapeutic and medical imaging applications: colon, stomach, leukemia, lung and prostate.
First Light Biosciences, Inc. (First Light Biosciences) is a medical diagnostic products provider. It develops products based on its proprietary multiPath technology.
Spectral Molecular Imaging, Inc. (SMI) is a medical imaging device company. It focuses on the development of medical products based on proprietary technology.
Enzo Life Sciences, Inc. (Enzo Life Sciences) is a wholly owned subsidiary of Enzo Biochem, Inc. The company provides life science research reagents. Enzo Life Sciences also offers labeling and detection technologies throughout research and diagnostic fields. The companys product portfolio include fluorescent dyes, assay kits, small molecules, proteins, antibodies, proteins, peptides and other related compounds.
MetaStat, Inc., (MetaStat) formerly known as Photovoltaic Solar Cells Inc., is a life science company. It focuses on the development of proprietary clinical diagnostic tests.
Cleveland Heart, Inc. (Cleveland) develops mechanical cardiac circulatory assist devices to treat heart failure patients. It offers SmartHeart Left Ventricular Assist Device (LVAD) which is a battery-operated mechanical device that is surgically implanted to maintain the pumping ability of heart, which cant work on its own. LVADs are used to bridge patients until the donor heart becomes available or as a long-term alternative for heart transplantation.
On-Q-ity, Inc. (On-Q-ity) is a diagnostic company. It focuses on providing physicians with the tools they need to make the best decision when treating individual cancer patients.
Advanced BioMedical Technologies Inc. (ABMT) is a development-stage company, involved in the business of designing, developing, manufacturing and marketing of self-reinforced, re-absorbable biodegradable internal fixation devices. The companys polyamide materials are used in manufacturing screws, binding wires, rods and related products.
Enzo Life Sciences, Inc. (Enzo Life Sciences) is a wholly owned subsidiary of Enzo Biochem, Inc. The company provides life science research reagents. Enzo Life Sciences also offers labeling and detection technologies throughout research and diagnostic fields.
Big Market Research present “Global Biosimilars Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2018. Visit for more info @ http://www.bigmarketresearch.com/global-biosimilars-2014-2018-market The Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing.
Courtagen Life Sciences, Inc. (Courtagen), formerly known as Avantra Biosciences Corporation, is a life science company. It focuses on offering genomic and proteomic products and services for the treatment of neurological and metabolic disorders. The companys product portfolio consists of POC protein biomarker technologies, namely, Avantra Q400 biomarker workstation and QPDx biochip. These products allow scientists and clinicians to conduct multiplex biomarker analysis for research use only from their lab bench or clinical trial site.
The major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd... @ @ https://bit.ly/3h7BVom
Market Research Future Publish New Market Research Report On-“Levulinic Acid Market 2021 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2027”
The major players covered in the Coronavirus (COVID-19) Current Therapy Global Market Report are Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, Regeneron Pharmaceuticals, Applied DNA Sciences, Inc, Codagenix, GeoVax Labs, Inc., Takis Biotech, Evvivax, Zydus Cadila, MIGAL Galilee Research Institute, Generex Biotechnology Corporation,
Looking forward, the Menswear market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/menswear-market
Looking forward, the transfection technologies market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/transfection-technologies-market
Looking forward, the array instruments market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/array-instruments-market
Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product. Check complete report @ http://www.marketintelreports.com/report/IRTNTR10349/global-mab-biosimilars-market-20162020
Get Sample Copy of report @ http://www.bigmarketresearch.com/request-sample/695240 Big Market Research provides new report package “Global mAb Biosimilars Market- Size, Share, Trends, Forecast, Growth, Opportunities 2020” The global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of 4-7% during the period 2015-2020.
In this report, the global Human Papillomavirus Protein E7 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
The Fabry Disease Treatment Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of fabry disease treatment.
Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market. Complete report of 106 Pages is available @ http://www.sandlerresearch.org/global-biosimilars-market-2014-2018.html
The global personal protective equipment market is projected to cross $ 93 billion by the end of 2025. Personal protective equipment is intended to ensure adequate safety for laborers and limit any wellbeing and security dangers.
Complete report on Hereditary Angioedema industry spread across 64 pages with providing 4 company profiles, 3 tables and 35 figures is now available at http://www.marketreportsonline.com/584779.html.
Tim Southey, Greenview Nursery Company. Gary Ash, 1st Farm Credit Services ... Dr. Gary Minish, Southern Illinois University. Philip Nelson, Illinois Farm Bureau ...
Acute Bronchitis -API Insights, 2014 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Acute Bronchitis. It also provides the India and China API Manufactures who are driving the current API Market. See Full Report @ bit.ly/1BPzoHh